Therapeutic mAbs has developed from reshaping antibody and humanized antibody to fully human antibody in order to lower supersensitivity resulting from mouse antibody.

为降低鼠抗体引起的超敏反应,疗性单克隆抗体已由改型抗体,抗体发展到全抗体。